Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 2002

View Archived Issues

The CXCR4-CXCL12/SDF-1 pathway is a possible target for non-Hodgkin's lymphoma therapy

Pagoclone is reported as safe and effective in the treatment of panic disorder

Tiotropium is better than salmeterol in improving lung function in COPD patients

Amersham provides interim update on product development

IND cleared for diclofenac sodium i.v. for acute moderate to severe pain

ProlX receives SBIR grant to advance HIF inhibitor cancer therapy

Initial phase I results for Large Scale Biology's personalized NHL vaccines

aaiPharma's board of directors approve Tanabe Seiyaku joint venture

Athersys expands BMS collaboration

EyeTech completes enrollment in two pivotal Macugen trials

Biomed-101 phase Ib enrollment completed

Targeted Genetics restructures

First in vitro study of P80DOX-NP completed

Immune Network licenses dapsone preclinical data from Atrix

Novel compounds for drug delivery identified at GSK and Cambridge University

Egis presents new AMPA antagonists for use in stroke, anxiety, etc.

Novel thrombin inhibitors in Merck & Co. pipeline

New compounds with LTP-stimulating activity disclosed by Fujisawa

Servier and INSERM jointly report new antiarthritic agents

Risperdal Consta approved in U.K.